1. Kuroda of the Bank of Japan may not have seen the need for more stimulus as per his comments at Jackson Hole...but the yen begged to differ:
2. This is very good on the 'real wage debate' in the US comparing the impact of different inflation measures:
3. A new guest post author on Financial Orbit highlights that GlaxoSmithKline is starting to look a little more interesting than average...
4. ...meanwhile Roche spends the odd US$8bn on another pharma sector deal.
5. Finally, what a great US economic and earnings weekly calendar by @WrigleyTom




No comments:
Post a Comment